While Mecp2 was overexpressed in estrogen receptor positive human breast cancer (Muller et al., 2003), MBD1 mRNA and protein levels were increased in prostate cancer (Patra et al., 2003). The gene discussed is MBD1; the disease is prostate carcinoma.